Skip to main content

AKANDA CORP.

corporate_fare Company Profile

AKANDA CORP.

AKAN·NASDAQ·Life Sciences·CIK 0001888014

AKANDA CORP. operates in the cannabis cultivation, manufacturing, and distribution sector. The company has a limited operating history and minimal revenues to date. AKANDA CORP. plans to expand its cultivation operations and develop sales channels for its cannabis products. On September 19, 2023, AKANDA CORP. entered an option to purchase agreement for Canadian farming property located at 1900 Ferne Road, Gabriola Island, British Columbia, including related operations and licenses, from 1107385. This agreement was amended and restated on September 22, 2023. The company intends to develop THC and CBD facilities at this site. AKANDA CORP. agreed to make a non-refundable payment of $1,800,000, structured in three payments. The first payment was made on September 22, 2023, by issuing 156 Common Shares. The second payment of $600,000 and the third payment of $600,000 were made on April 4, 2024. Additional payments to the seller are contingent upon achieving development milestones, including THC cultivation, product sales, CBD cultivation, and hemp cultivation. On September 5, 2024, Health Canada approved a hemp license for AKANDA CORP.'s subsidiary, 1468243 B.C. LTD, which triggered a milestone requiring an additional payment of $750,000 to the seller. This payment was made on September 16, 2024. On September 24, 2025, AKANDA CORP. amended the option agreement, extending the option term to September 25, 2027, for an extension fee of $250,000. The first payment of $150,000 for this extension was made on September 25, 2025. As of the filing date, AKANDA CORP. has not yet cultivated any product from this land. The Canadian hemp industry stabilized around 29,309 acres in 2023.

AKANDA CORP. (NASDAQ:AKAN) is a publicly traded company in the Life Sciences sector. Wiseek monitors AKAN SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • AKANDA CORP. Announces 1-for-5 Reverse Stock Split to Boost Share Price

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$258.07K
Net Income
-$45.65M
Diluted EPS
-$662.22
Op. Cash Flow
-$6.73M
Free Cash Flow
-$7.96M
Gross Profit
-$156.02K
Operating Income
-$4.98M
Cash & Equivalents
$503.56K
Debt / Equity
0.00×
Net Margin
-176.90×
Source: 20-F · filed 2026-06-09 · accession 0001213900-26-066800

Insider Transactions

AKAN files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.

$18.5 -0.04% today
52-week range · as of 2026-06-12 $2.29 – $209.03
Market cap
$10.03M
Volume
5.4M (5.4× avg)
3-mo avg 1M
Live data · 2026-06-14 05:28 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed AKAN - Filings & News (Page 2)

AKAN
Jan 08, 2026, 8:00 AM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.558
Real-time Price: $18.50 info
Change: +$17.94 (+3,215%) info
Market Cap: $10.027M info